Blog
Fix Price Group PLC: Notification of PDMR transaction
Fix Price Group PLC: Notification of PDMR transaction
Long Term Incentive Plan (“LTIP”) Award
Long Term Incentive Plan (“LTIP”) Award
EQS-News: audius SE: Re-placement increases free float of audius shares
EQS-News: audius SE: Re-placement increases free float of audius shares
Lenta IPJSC: Lenta Announces the Holding of the Board of Directors Meeting
Lenta IPJSC: Lenta Announces the Holding of the Board of Directors Meeting
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
Form 8.3 - The Vanguard Group, Inc.: Devro plc
Form 8.3 - The Vanguard Group, Inc.: Devro plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
EQS-News: Eurobattery Minerals AB: Eckhard Cordes, Chairman of the Board of Bilfinger SE, exercises warrants of series TO3 together with Board and Management
EQS-News: Eurobattery Minerals AB: Eckhard Cordes, Chairman of the Board of Bilfinger SE, exercises warrants of series TO3 together with Board and Management
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
EQS-News: Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
EQS-News: Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
EQS-News: Cliq nominated for “Excellence in Brand Strategy and Creation” as well as for “Excellent Brand”
EQS-News: Cliq nominated for “Excellence in Brand Strategy and Creation” as well as for “Excellent Brand”
EQS-News: edding Aktiengesellschaft: edding postpones publication date for 2022 annual report
EQS-News: edding Aktiengesellschaft: edding postpones publication date for 2022 annual report
Chelverton UK Dividend Trust plc: Monthly Factsheet
Chelverton UK Dividend Trust plc: Monthly Factsheet
EQS-News: Evotec and Bristol Myers Squibb extend and expand strategic neurodegeneration partnership
EQS-News: Evotec and Bristol Myers Squibb extend and expand strategic neurodegeneration partnership
EQS-Adhoc: Evotec and Bristol Myers Squibb expand strategic neurodegeneration partnership
EQS-Adhoc: Evotec and Bristol Myers Squibb expand strategic neurodegeneration partnership
Superdry plc: BLR-Block listing Interim Review*
Superdry plc: BLR-Block listing Interim Review*
OSSIAM RISK WEIGHTED ENHANCED COMMODITY EX GRAINS TR UCITS ETF: Notice to Shareholders
OSSIAM RISK WEIGHTED ENHANCED COMMODITY EX GRAINS TR UCITS ETF: Notice to Shareholders
EQS-News: ElringKlinger completes 2022 financial year with successful operating performance
EQS-News: ElringKlinger completes 2022 financial year with successful operating performance
EQS-News: TTL Beteiligungs- und Grundbesitz-AG: TTL publishes Annual Report 2022
EQS-News: TTL Beteiligungs- und Grundbesitz-AG: TTL publishes Annual Report 2022
EQS-News: IBU-tec advanced materials AG: Dr. Arndt Schlosser to Step Down from the Executive Board
EQS-News: IBU-tec advanced materials AG: Dr. Arndt Schlosser to Step Down from the Executive Board
EQS-Adhoc: Brockhaus Technologies AG: Brockhaus Technologies AG publishes forecast for fiscal year 2023
EQS-Adhoc: Brockhaus Technologies AG: Brockhaus Technologies AG publishes forecast for fiscal year 2023
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement


